Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
Carina holds a Doctor of Philosophy degree and has more than 15 years of experience in genetics, cell biology and molecular biology.
Previously, Carina has worked at the Institute of Molecular Medicine Finland (FIMM) and at the National Institute for Health and Welfare (THL).
A warm welcome to Tintti!
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
How to review and analyse a million sentences? Text mining decreased the work of clinical experts and accelerated the research process.
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.